Wasatch Advisors Inc Atri Cure, Inc. Transaction History

Wasatch Advisors Inc

$19.9 Billion
Q4 2024

A detailed history of Wasatch Advisors Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 607,364 shares of ATRC stock, worth $19.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

607,364

Previous 769,252 21.04%

Holding current value

$19.3 Million

Previous $21.6 Million 13.95%

% of portfolio

0.09%

Previous 0.11%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$27.02 - $38.2 $4.37 Million - $6.18 Million	-161,888 Reduced 21.04%	607,364 $18.6 Million
Q3 2024 Nov 14, 2024	SELL	$20.34 - $29.5 $418,231 - $606,579	-20,562 Reduced 2.6%	769,252 $21.6 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $1.37 Million - $2.01 Million	69,137 Added 9.59%	789,814 $18 Million
Q1 2024 Apr 18, 2024	BUY	$28.21 - $37.78 $5.66 Million - $7.59 Million	200,799 Added 38.62%	720,677 $21.9 Million
Q4 2023 Feb 14, 2024	SELL	$32.99 - $43.25 $1.43 Million - $1.88 Million	-43,410 Reduced 7.71%	519,878 $18.6 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $1.84 Million - $2.59 Million	-44,844 Reduced 7.37%	563,288 $24.7 Million
Q2 2023 Aug 07, 2023	BUY	$40.44 - $49.6 $7,926 - $9,721	196 Added 0.03%	608,132 $30 Million
Q1 2023 May 12, 2023	BUY	$35.87 - $47.22 $6.22 Million - $8.19 Million	173,354 Added 39.89%	607,936 $25.2 Million
Q4 2022 Feb 14, 2023	SELL	$33.48 - $47.45 $148,751 - $210,820	-4,443 Reduced 1.01%	434,582 $19.3 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $5.55 Million - $7.64 Million	145,195 Added 49.41%	439,025 $17.2 Million
Q2 2022 Aug 12, 2022	SELL	$35.1 - $66.01 $165,601 - $311,435	-4,718 Reduced 1.58%	293,830 $12 Million
Q1 2022 May 13, 2022	BUY	$57.43 - $71.39 $4.41 Million - $5.48 Million	76,765 Added 34.61%	298,548 $19.6 Million
Q4 2021 Feb 15, 2022	SELL	$63.4 - $87.14 $22,570 - $31,021	-356 Reduced 0.16%	221,783 $15.4 Million
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $118,399 - $144,342	1,709 Added 0.78%	222,139 $15.4 Million
Q2 2021 Aug 12, 2021	SELL	$64.13 - $80.18 $16.4 Million - $20.5 Million	-255,222 Reduced 53.66%	220,430 $17.5 Million
Q1 2021 May 10, 2021	SELL	$53.79 - $66.98 $3.54 Million - $4.41 Million	-65,893 Reduced 12.17%	475,652 $31.2 Million
Q4 2020 Feb 12, 2021	SELL	$34.56 - $57.55 $13.2 Million - $22 Million	-381,437 Reduced 41.33%	541,545 $30.1 Million
Q3 2020 Nov 10, 2020	BUY	$38.36 - $46.91 $4.43 Million - $5.41 Million	115,395 Added 14.29%	922,982 $36.8 Million
Q2 2020 Aug 12, 2020	BUY	$31.78 - $51.19 $1.87 Million - $3.01 Million	58,736 Added 7.84%	807,587 $36.3 Million
Q1 2020 May 08, 2020	BUY	$24.49 - $43.84 $1.62 Million - $2.91 Million	66,298 Added 9.71%	748,851 $25.2 Million
Q4 2019 Feb 13, 2020	SELL	$24.06 - $32.51 $127,373 - $172,107	-5,294 Reduced 0.77%	682,553 $22.2 Million
Q3 2019 Nov 14, 2019	BUY	$23.81 - $32.52 $381,221 - $520,677	16,011 Added 2.38%	687,847 $17.2 Million
Q2 2019 Aug 07, 2019	BUY	$26.85 - $30.74 $2.86 Million - $3.27 Million	106,475 Added 18.83%	671,836 $0
Q1 2019 May 08, 2019	BUY	$26.38 - $33.34 $4.39 Million - $5.55 Million	166,578 Added 41.77%	565,361 $0
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $26,819 - $35,059	-1,006 Reduced 0.25%	398,783 $12.2 Million
Q3 2018 Nov 07, 2018	BUY	$27.62 - $35.58 $885,221 - $1.14 Million	32,050 Added 8.72%	399,789 $0
Q2 2018 Aug 02, 2018	SELL	$19.65 - $30.28 $374,352 - $576,864	-19,051 Reduced 4.93%	367,739 $0
Q1 2018 May 02, 2018	SELL	$15.05 - $21.03 $529,970 - $740,550	-35,214 Reduced 8.34%	386,790 $0
Q4 2017 Jan 16, 2018	SELL	$17.69 - $23.44 $34,654 - $45,918	-1,959 Reduced 0.46%	422,004 $0
Q3 2017 Nov 08, 2017	SELL	$20.0 - $24.23 $266,820 - $323,252	-13,341 Reduced 3.05%	423,963 $0
Q2 2017 Aug 16, 2017	BUY	N/A	437,304	437,304 $0

Others Institutions Holding ATRC

# of Institutions

228

Shares Held

46.4M

Call Options Held

25.8K

Put Options Held

4.5K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.48B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Account

Wasatch Advisors Inc Atri Cure, Inc. Transaction History